Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AXS-07
AXS-07
As expected, FDA spikes down Axsome migraine med, but issues are 'addressable'
Fierce Biotech
Mon, 05/2/22 - 06:19 pm
Axsome Therapeutics
migraines
FDA
AXS-07
It's CRL Day at the FDA as Axsome, Junshi and Coherus Get Bad News
BioSpace
Mon, 05/2/22 - 11:44 am
FDA
complete response letter
Junshi Biosciences
Coherus Biosciences
Axsome Therapeutics
migraines
AXS-07
Axsome expects migraine drug to be rejected as manufacturing issues arise
Endpoints
Mon, 04/25/22 - 10:42 am
Axsome Therapeutics
migraines
FDA
AXS-07
Axsome’s Migraine Drug Provides Relief in Phase III Trial
BioSpace
Sun, 01/3/21 - 04:19 pm
Axsome Therapeutics
clinical trials
AXS-07
migraines
Clinical developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:35 pm
Google Health
Axsome
Spectrum Pharmaceuticals
Wave Life Sciences
Google DeepMind
AXS-07
WVE-120102
poziotinib
Upcoming events – Axsome takes on migraine and Kala looks to dry eye again
EP Vantage
Sun, 11/10/19 - 07:58 pm
Axsome Therapeutics
migraines
AXS-07
Kala Pharmaceuticals
clinical trials
KP-121
dry eye disease
